These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38321946)

  • 1. 2,4,6-Trimethoxy chalcone derivatives: an integrated study for redesigning novel chemical entities as anticancer agents through QSAR, molecular docking, ADMET prediction, and computational simulation.
    Chitre TS; Mandot AM; Bhagwat RD; Londhe ND; Suryawanshi AR; Hirode PV; Bhatambrekar AL; Choudhari SY
    J Biomol Struct Dyn; 2024 Feb; ():1-24. PubMed ID: 38321946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico studies of 2-aminothiazole derivatives as anticancer agents by QSAR, molecular docking, MD simulation and MM-GBSA approaches.
    Chitre TS; Hirode PV; Lokwani DK; Bhatambrekar AL; Hajare SG; Thorat SB; Priya D; Pradhan KB; Asgaonkar KD; Jain SP
    J Biomol Struct Dyn; 2023 Oct; ():1-19. PubMed ID: 37811574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into benzene sulphonamide substituted diarylpyrazoles as cyclooxygenase-2 inhibitor and its structural modifications.
    Priya D; Kathiravan MK
    J Biomol Struct Dyn; 2021 Sep; 39(14):5093-5104. PubMed ID: 32602808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies.
    Bathula S; Sankaranarayanan M; Malgija B; Kaliappan I; Bhandare RR; Shaik AB
    ACS Omega; 2023 Nov; 8(46):44287-44311. PubMed ID: 38027360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new oxadiazolo pyridine derivatives as potent ghrelin O-acyltransferase inhibitors using molecular modeling techniques.
    Sarkar K; Das B; Das RK
    In Silico Pharmacol; 2023; 11(1):35. PubMed ID: 37954893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation approach of hybrid chalcone-thiazole complex derivatives for DNA gyrase B inhibition: lead generation.
    Patan A; Aanandhi M V; P G
    RSC Adv; 2023 Aug; 13(35):24291-24308. PubMed ID: 37583661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
    Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
    J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined
    Guendouzi A; Belkhiri L; Guendouzi A; Derouiche TMT; Djekoun A
    J Biomol Struct Dyn; 2024; 42(1):119-133. PubMed ID: 36995063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
    Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
    Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into structures of imidazo oxazines as potent polyketide synthase XIII inhibitors using molecular modeling techniques.
    B S; M K K
    J Recept Signal Transduct Res; 2020 Aug; 40(4):313-323. PubMed ID: 32228125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
    Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
    Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and
    Jawarkar RD; Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Masand V; Humane V; Mali S; Alzahrani AYA; Rashid S; Elossaily GM
    J Biomol Struct Dyn; 2024 Feb; ():1-31. PubMed ID: 38385447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.
    Khamouli S; Belaidi S; Ouassaf M; Lanez T; Belaaouad S; Chtita S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1285-1298. PubMed ID: 32964807
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship and molecular docking studies on human proteasome inhibitors for anticancer activity targeting NF-κB signaling pathway.
    Yadav D; Mishra BN; Khan F
    J Biomol Struct Dyn; 2020 Aug; 38(12):3621-3632. PubMed ID: 31514715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.